mPOCT, Real-Time PCR System
BRIEFInnovations in molecular assays—especially on the point-of-care testing (POCT) front—have spread this testing from molecular diagnostics laboratories into clinical microbiology laboratories—and now into general laboratories and even clinics and exam rooms.  Access to sensitive and rapid infectious disease diagnostic assays is essential for accurate diagnosis, effective treatment, and timely infection control, making POCT vital to reducing TAT. With novel POCT on the horizon, future studies are warranted to determine cost savings, antimicrobial usage, TAT, patient impact, and how to best implement in non-microbiology clinical laboratories and clinics.  Sansure iPonatic (Portable Molecule Workstation) aims to subvert traditional diagnostic mode and bring precision healthcare into thousands of households. It can provide quickly and convenient diagnosis experience for clinical emergency, health management, military safety, biological emergency and other applications.
- Rapid nucleic acid lysis at room temperature within 1 minute
- Ultra fast amplification system in 8-45 minutes
- Integrated automatic data analysis software
- Results immediately printed by built-in printer
Diagnostic results consistent with international mainstream PCR instruments
Model S-Q31A S-Q31B Detection platform Real-time PCR Detection module 1 amplification module 4 amplification modules Temperature control Liquid metal coated ceramic heating / Air cooling technology Heating rate ≥6.0℃ /s (from 50℃ to 95℃ ) Cooling rate ≥2.0℃ /s (from 95℃ to 50℃ ) Excitation light source LED Detector High sensitivity photodiode Applicable dyes FAM VIC ROX CY5 Sensitivity Can detect single copy gene Electrical specification AC 100-200V 50/60Hz Dimension 230×284×376 mm (L×W×H) 336.5 × 280 × 435 mm (L×W×H) Weight 9.7Kg 13Kg
TEST MENURespiratory Infections : SARS-CoV-2, SARS-CoV-2/FluA/B, MP, ADV, BP.... HPV Infections : HrHPV, HPV 13+2, HPV 16/18, HPV 6/11.... Children's health : EBV, HCMV.... STIs : CT/UU/NG, CT, UU, NG, HSV-2.... Other test projects are under development
. Kozel TR, Burnham-Marusich AR. Point-of-care testing for infectious diseases: Past, present, and future. J Clin Microbiol 2017;55:2313-20.
. Paige M.K. Larkin, Omai B. Garner. Molecular Point-of-Care Testing in Clinical Laboratories Laboratorians can lead a new era in rapid testing with expertise in quality control and result interpretation. Clinical Laboratory News. JUL.1.2020
COVID-19 Diagnosis, mPOCT
BRIEFCOVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Sansure COVID-19 diagnostic solutions are used to directly detect the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness.
- One-tube/fast release technology
- Up to 96 samples at one time
- Simple operation process, less specialist training
- Room temperature lysis, less contamination
- Sampling types : nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood ,Feces
- Enhance large-scale screening efficiency
- Internal control: human housekeeping gene RNase P
Product features Parameters Specimen Type Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood, feces Extraction Platform One-tube fast release technology Advanced magnetic beads technology Internal Control Rnase P gene PCR Instrument ABI7500, QuantStudioTM 5, SLAN-96P, MA-6000, Bio-Rad CFX-96, QuantGene 9600, LightCycler 480, iPonatic S-Q31A&B,S-Q36A Sensitivity 200 copies/mL Spec. 24T, 48T, 24-P